Search
Search Results
-
Mucormycosis: A Rare disease to Notifiable Disease
Mucormycosis is the third most frequent invasive mycosis, following candidiasis and aspergillosis. It is frequently neglected due to its rare...
-
Emerging Mucormycosis: Problems and Treatments
Fungi of the order Mucorales and class Zygomycetes cause mucormycosis that is opportunistic and rapidly emerging. In recent years, an increase in...
-
Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review
Although mucormycosis may have reached an epidemic situation during the COVID-19 pandemic, the term was much more familiar even before the COVID-19...
-
Mucormycosis in Human Immunodeficiency Virus-Infected Individuals: A Systematic Review of Case Reports
Mucormycosis in human immunodeficiency virus (HIV) infection is uncommon; notably, many cases have additional predisposing factors. Whether...
-
Advancements of fish-derived peptides for mucormycosis: a novel strategy to treat diabetic compilation
Mucormycosis, an extremely fatal fungal infection, is a major hurdle in the treatment of diabetes consequences. The increasing prevalence and...
-
Biotic environment reinforcing the pertinacious clinically relevant COVID-19 associated mucormycosis: First report from Kashmir valley, India
Immuno-compromised COVID-19 patients being treated with glucocorticoids like Dexamethasone for prolonged periods had led to the surge of...
-
Mixed Aspergillosis and Mucormycosis Infections in Patients with COVID-19: Case Series and Literature Review
BackgroundMucormycosis and aspergillosis are angioinvasive infections mainly occurring in immunocompromised patients. However, mixed infection with...
-
COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challenges
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic is still difficult to be controlled. The spread of this virus and the...
-
Utility of Itraconazole in Combination with Liposomal Amphotericin B in Rhizopus oryzae Associated Mucormycosis–An Exploratory Study
BackgroundDuring the COVID-19 pandemic-associated mucor epidemic, acute antifungal drug shortage necessitated the exploration of other antifungals...
-
Satellite Epidemic of Covid-19 Associated Mucormycosis in India: A Multi-Site Observational Study
BackgroundSudden upsurge in cases of COVID-19 Associated Mucormycosis (CAM) following the second wave of the COVID-19 pandemic was recorded in India....
-
COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran
BackgroundDespite the unprecedented surge in the incidence of mucormycosis in the COVID-19 era, the antifungal susceptibility patterns (ASPs) of...
-
Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study
BackgroundCOVID-19 associated mucormycosis (CAM) has been known as one of the most severe post-COVID morbidities.
ObjectivesTo describe CAM cases,...
-
Vitamin A Deficiency, COVID-19, and Rhino-Orbital Mucormycosis (Black Fungus): An Analytical Perspective
Mucormycosis is a rare but serious opportunistic fungal disease characterized by rhino-orbito-cerebral and pulmonary involvement. It is mainly seen...
-
Changing Trend of Risk Factors of Mucormycosis Including Diabetes, Acidosis, and Serum Iron in the Second Wave of COVID-19
To analyze the clinic-pathological profile of patients presenting with mucormycosis infection to a tertiary care center during the second wave of the...
-
Mucormycosis in Mainland China: A Systematic Review of Case Reports
BackgroundMucormycosis is a lethal fungal infection with increasing incidence. The epidemiology of mucormycosis in current mainland China has not...
-
Antifungal activity of silver nanoparticles on fungal isolates from patients of suspected mucormycosis
IntroductionThe present study aimed to investigate the antifungal activity of silver nanoparticles (SNPs) against agents of suspected rhino orbital...
-
Coinfection pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin in an acute B-lymphoblastic leukemia patient
Pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin is a very rare but lethal infection leading to...
-
Antifungal Activity of Chitosan Polymeric Nanoparticles and Correlation with Their pH Against Mucor circinelloides Causing Mucormycosis, Along with Penicillium notatum and Aspergillus Species
Mucormycosis is uncommon, yet it is more prevalent among individuals with underlying health conditions and those who are immunocompromised. Chitosan...
-
Serum glucose-regulated protein 78 (GRP78) levels in COVID-19-associated mucormycosis: results of a case–control study
BackgroundIn experimental models, the expression of glucose-regulated protein 78 (GRP78) in endothelial cells played a role in the pathogenesis of...
-
Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients
Mucormycosis, also called “Black Fungus”, is a new cause for worry in the current Coronavirus disease 2019 (covid-19) pandemic. Mucormycosis is...
